Synergistic Benefit of Adoptive T Cells in Combination With Chemoradiotherapy Against Metastatic Prostate Cancer Cells

Yun Chu Shen, Hung Jen Shih, Chi Chien Lin, Sheng Hsien Huang, Sheng Chuan Wu, Chi Hao Hsiao, Shao Chi Chiu, DER E.R.Y. Cho, Chin Pao Chang, Yueh Pan, Ping Hsiao Shih

研究成果: 雜誌貢獻文章同行評審

1 引文 斯高帕斯(Scopus)

摘要

BACKGROUND/AIM: Prostate cancer (PC) is one of the major diseases that affects male health and ranks as the second most frequent cancer in men worldwide. Although most newly-diagnosed PCs are well-differentiated tumors with a high cure probability, there are some patients with aggressive malignancies that show potential for recurrence and metastasis. Cytotoxic T lymphocytes are a specific immune effector cell population that mediates immune responses against cancer. MATERIALS AND METHODS: In the present study, the cytotoxicity of peripheral blood mononuclear cells (PBMCs)-derived γδ T cells and cytokine-induced killer (CIK) cells in combination with chemoradiotherapy against PC cells was evaluated using Alamar blue cell viability and cell membrane permeability assays. RESULTS: Advanced PC-3 cells, which were more resistant to docetaxel (Doc), also showed higher viability following pretreatment with radiation. The cell proliferation inhibition was significantly increased upon additional γδ T or CIK treatment. Furthermore, the proportion of apoptotic cells was significantly (p
原文英語
頁(從 - 到)3427-3434
頁數8
期刊Anticancer Research
42
發行號7
DOIs
出版狀態已發佈 - 7月 1 2022

ASJC Scopus subject areas

  • 腫瘤科
  • 癌症研究

指紋

深入研究「Synergistic Benefit of Adoptive T Cells in Combination With Chemoradiotherapy Against Metastatic Prostate Cancer Cells」主題。共同形成了獨特的指紋。

引用此